E-LIB Suche - Ergebnisse für: Mok, NY

1

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800..:

Pasqua, AE ; Sharp, SY ; Chessum, NEA...
Journal of Medicinal Chemistry, 2023, 66 (8), pp. 5907 - 5936. , 2023

2

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800..:

Pasqua, AE ; Sharp, SY ; Chessum, NEA...
https://discovery.ucl.ac.uk/id/eprint/10184910/1/HSF1%20Pathway%20Inhibitor%20Clinical%20Candidate%20%28CCT361814NXP800%29%20Developed%20from%20a%20Phenotypic%20Screen%20as%20a%20Potential%20Treatment%20for%20.pdf. , 2023

Link: https://discovery.ucl.ac..

3

C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies t..:

Le Bihan, Y-V ; Lanigan, RM ; Atrash, B...
European journal of medicinal chemistry, 2019, 177 pp. 316 - 337. , 2020

Link: https://repository.icr.a..

4

8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives ..:

Bavetsias, V ; Lanigan, RM ; Ruda, GF...
Journal of medicinal chemistry, 2016, 59 (4), pp. 1388 - 1409. , 2020

Link: https://repository.icr.a..

5

Binding to an Unusual Inactive Kinase Conformation by Highl..:

Colombano, G ; Caldwell, JJ ; Matthews, TP...
Journal of medicinal chemistry, 2019, 62 (5), pp. 2447 - 2465. , 2019

Link: https://repository.icr.a..

6

C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies t..:

Le Bihan, Y-V ; Lanigan, RM ; Atrash, B...
doi:10.1016/j.ejmech.2019.05.041. , 2019

Link: https://doi.org/10.1016/..

7

Privileged Structures and Polypharmacology within and betwe..:

Meyers, J ; Chessum, NEA ; Ali, S...
ACS medicinal chemistry letters, 2018, 9 (12), pp. 1199 - 1204. , 2018

Link: https://repository.icr.a..

8

Pyrido[3,4-d]pyrimidin-4(3H)-one metabolism mediated by ald..:

Hayes, A ; Mok, NY ; Liu, M...
Xenobiotica; the fate of foreign compounds in biological systems, 2017, 47 (9), pp. 771 - 777. , 2017

Link: https://repository.icr.a..

9

2024 Hong Kong College of Obstetricians and Gynaecologists ..:

Cheung, KW ; So, PL ; Mak, Loey LY...
Hong Kong Medical Journal. , 2024

Link: https://doi.org/10.12809..

10

A blood-based multi-pathway biomarker assay for early detec..:

Jiang, Y ; Uhm, H ; Ip, FC...
https://discovery.ucl.ac.uk/id/eprint/10185753/1/A%20blood%20based%20multi%20pathway%20biomarker%20assay.pdf. , 2024

Link: https://discovery.ucl.ac..

11

An IL1RL1 genetic variant lowers soluble ST2 levels and the..:

Jiang, Y ; Zhou, X ; Wong, HY...
issn:2662-8465. , 2022

Link: http://hdl.handle.net/11..

12

Large-scale plasma proteomic profiling identifies a high-pe..:

Jiang, Y ; Zhou, X ; Ip, FC...
https://discovery.ucl.ac.uk/id/eprint/10129542/7/Hardy_Alzheimer%20s%20%20%20Dementia%20-%202021%20-%20Jiang%20-%20Large%E2%80%90scale%20plasma%20proteomic%20profiling%20identifies%20a%20high%E2%80%90performance%20biomarker.pdf. , 2022

Link: https://discovery.ucl.ac..

13

Genetic and polygenic risk score analysis for Alzheimer's d..:

Zhou, X ; Chen, Y ; Ip, FCF...
https://discovery.ucl.ac.uk/id/eprint/10108729/1/dad2.12074%20%281%29.pdf. , 2020

Link: https://discovery.ucl.ac..

14

Non-coding variability at the APOE locus contributes to the..:

Zhou, X ; Chen, Y ; Mok, KY...
https://discovery.ucl.ac.uk/id/eprint/10082333/1/Hardy_Non-coding%20variability%20at%20the%20APOE%20locus%20contributes%20to%20the%20Alzheimer%27s%20risk_VoR.pdf. , 2019

Link: https://discovery.ucl.ac..

15

Identification of genetic risk factors in the Chinese popul..:

Zhou, X ; Chen, Y ; Mok, KY...
https://discovery.ucl.ac.uk/id/eprint/10045023/1/1697.full.pdf. , 2018

Link: https://discovery.ucl.ac..